The COMPASSION Study

Description

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.

Conditions

Breast Cancer, Metastatic Breast Cancer, Advanced Breast Cancer, Unresectable Breast Carcinoma

Talk to us

Study Overview

On this page

Study Details

Study overview

The aim of this research study is to better understand the in-home hospice experience for participants, caregivers, hospice nurses, and oncology providers by conducting telehealth check-ins between participants and caregivers and oncology care teams.

The COMPASSION Study: Applying Telehealth to Innovate and Strengthen Connections for Patients with Metastatic Breast Cancer Receiving Hospice Care

The COMPASSION Study

Condition
Breast Cancer
Intervention / Treatment

-

Contacts and Locations

Boston

Dana-Farber Cancer Institute, Boston, Massachusetts, United States, 02215

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Patient of any gender with unresectable locally advanced or metastatic breast cancer
  • * Eligible for in-home hospice services and referred by DFCI clinical team to in-home hospice \</= 1 week before enrollment
  • * Ability to conduct video or phone check-ins, even if assistance required.
  • * Able to provide verbal consent with a willingness to take a survey at 4-6 weeks, if medically able
  • * Hospice setting is within Massachusetts
  • * Non-English language allowed but interpreter services must be present at each meeting and will be coordinated by scheduling team
  • * Willingness to provide a caregiver/loved one's contact information for survey contact at 4 weeks after enrollment
  • * Unable to provide verbal consent
  • * Hospice care planned outside of a home setting (note: if participants start out in a home hospice setting but later transition their hospice care to an inpatient setting, enrollment is allowed as long as they started in a home setting)
  • * Hospice setting outside of Massachusetts
  • * Individuals who are under the age of 18, as this is not a project focused on pediatric patients.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Dana-Farber Cancer Institute,

Claire Smith, MD, PRINCIPAL_INVESTIGATOR, Dana-Farber Cancer Institute

Study Record Dates

2026-03-01